• Morgan Stanley sets a new price target of $63 for NYSE:BUD, indicating a potential 35% increase.
• The adjustment reflects recent market data and foreign exchange rates, with an Overweight rating maintained.
• Despite recent volatility and a decrease in share price, AB InBev shows potential for growth and "very attractive" cash returns in the latter half of the year.

AB InBev, listed on the NYSE under the symbol BUD, is a leading global brewer known for its extensive portfolio of beer brands. The company operates in various markets worldwide, facing competition from other major brewers like Heineken and Molson Coors. On January 9, 2025, Morgan Stanley's Sarah Simon set a price target of $63 for BUD, suggesting a potential 35% increase from its then-current price of $46.41.

Sarah Simon's revised price target of $63, down from $68.50, reflects recent market data and foreign exchange rates impacting AB InBev's profitability. Despite the adjustment, Simon maintains an Overweight rating, indicating confidence in the stock's potential.

The stock's recent performance shows a fluctuation between $46.10 and $48.38, with a 52-week high of $67.49 and a low of $46.10. This volatility highlights the challenges and opportunities in the market. AB InBev's market capitalization stands at approximately $91.58 billion, reflecting its significant presence in the industry.

Despite the potential for "very attractive" cash returns, Morgan Stanley anticipates more substantial growth and share price performance in the latter half of the year. This outlook has led to the removal of AB InBev as Morgan Stanley's "Top Pick" in the Beverages sector, as highlighted by the firm, due to better near-term opportunities elsewhere.

The trading volume for BUD is 5,487,167 shares, indicating active investor interest. As the year progresses, investors will likely monitor AB InBev's performance closely, considering the potential for growth and the impact of market conditions on its profitability.